Plasmonics, Journal Year: 2024, Volume and Issue: unknown
Published: June 17, 2024
Language: Английский
Plasmonics, Journal Year: 2024, Volume and Issue: unknown
Published: June 17, 2024
Language: Английский
Measurement, Journal Year: 2024, Volume and Issue: 231, P. 114652 - 114652
Published: April 6, 2024
Language: Английский
Citations
41Talanta, Journal Year: 2024, Volume and Issue: 275, P. 126080 - 126080
Published: April 10, 2024
Language: Английский
Citations
25Plasmonics, Journal Year: 2024, Volume and Issue: unknown
Published: July 27, 2024
Language: Английский
Citations
21Plasmonics, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 8, 2024
Language: Английский
Citations
20Small Science, Journal Year: 2024, Volume and Issue: 4(3)
Published: Jan. 22, 2024
Despite significant advancements in medical technology, cancer remains the world's second‐leading cause of death, largely attributed to late‐stage diagnoses. While traditional detection methodologies offer foundational insights, they often lack specificity, affordability, and sensitivity for early‐stage identification. In this context, development biosensors offers a distinct possibility precise rapid identification biomarkers. Carbon nanomaterials, including graphene, carbon nitride, quantum dots, other carbon‐based nanostructures, are highly promising detection. Their simplicity, high sensitivity, cost‐effectiveness contribute their potential field. This review aims elucidate emerging carbon‐nanomaterial‐based early diagnosis. The relevance various biosensor mechanisms performance physicochemical properties nanomaterials is discussed depth, focusing on demonstrating broad creating biosensors. Diverse techniques, such as electrochemical, fluorescence, surface plasmon resonance, electrochemiluminescence, quartz crystal microbalance, emphasized At last, summary existing challenges future outlook field elaborated.
Language: Английский
Citations
18Analytical Chemistry, Journal Year: 2024, Volume and Issue: 96(18), P. 6930 - 6939
Published: April 23, 2024
Circulating tumor DNA (ctDNA) holds great promise as a noninvasive biomarker for cancer diagnosis, treatment, and prognosis. However, the accurate specific quantification of low-abundance ctDNA in serum remains significant challenge. This study introduced, first time, novel exponential amplification reaction (EXPAR)-assisted CRISPR/Cas12a-mediated ratiometric dual-signal electrochemical biosensor ultrasensitive reliable detection ctDNA. To implement strategy, signal unit (ssDNA-MB@Fc/UiO-66-NH
Language: Английский
Citations
16Plasmonics, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 8, 2025
Language: Английский
Citations
9Biosensors, Journal Year: 2025, Volume and Issue: 15(1), P. 21 - 21
Published: Jan. 4, 2025
The COVID-19 pandemic has highlighted the urgent need for rapid, sensitive, and reliable diagnostic tools detecting SARS-CoV-2. In this study, we developed optimized a surface plasmon resonance (SPR) biosensor incorporating advanced materials to enhance its sensitivity specificity. Key parameters, including thickness of silver layer, silicon nitride dielectric molybdenum disulfide (MoS2) layers, ssDNA recognition were systematically achieve best balance between sensitivity, resolution, attenuation. configuration, consisting 45 nm 13 2 MoS2 5 demonstrated superior performance SARS-CoV-2 in PBS solution. exhibited high at low viral concentrations, achieving 375.01°/RIU, detection accuracy 0.002, quality factor 38.34 1.0 mM concentration. Performance metrics validated sensor’s capability detection, particularly early-stage diagnostics where timely intervention is critical. Moreover, biosensor’s linear response refractive index changes confirmed potential quantitative concentration analysis. This study underlines significance integrating materials, such as nitride, SPR performance. findings establish proposed robust precise tool with applications clinical epidemiological monitoring.
Language: Английский
Citations
2Chemical Physics Impact, Journal Year: 2023, Volume and Issue: 8, P. 100414 - 100414
Published: Dec. 5, 2023
In recent years, researchers have made significant contributions to the field of Surface Plasmon Resonance sensors and their potential applications. SPR features include real-time monitoring biomolecular interactions, label-free detection, high sensitivity, ability analyze multiple samples at same time. These characteristics make biosensors a valuable tool in pharmaceutical industry for ensuring drug efficacy safety. Furthermore, reputation providing quantitative qualitative superior performance applications such as development, environmental monitoring, food safety, medical diagnostics, clinical diagnosis, biological investigations, biomolecule interactions. This review will go over advances how they can be used discovery development. We also look challenges opportunities using industry.
Language: Английский
Citations
40Plasmonics, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 17, 2024
Language: Английский
Citations
14